September 01, 2016 12:39 AM ET

Biotechnology

Company Overview of Tesaro, Inc.

Executive Profile

Jeffrey H. Hanke Ph.D.

Chief Scientific Officer and Executive Vice President of Research & Development, Tesaro, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships
59$6,483,425
As of Fiscal Year 2015

Background

Dr. Jeffrey H. Hanke, also known as Jeff, PhD, has been the Chief Scientific Officer and Executive Vice President of Research & Development at Tesaro, Inc. since June 29, 2015. Dr. Hanke served as Vice President of Cancer Care Discovery of AstraZeneca. He joined AstraZeneca from Pfizer, where he managed discovery teams in the areas of immunology, inflammation, allergy/respiratory, and cancer from 1993 to 1999. In addition, he helped to establish Pfizer's Discovery Technology ...

Corporate Headquarters

1000 Winter Street
Waltham, Massachusetts 02451

United States

Phone: 339-970-0900
Fax: --

Board Members Memberships

There is no Board Members Memberships data available.

Education

PhD
Baylor College of Medicine
Post-Doctoral Training
University of Texas Southwestern Medical Center - Dallas
Master's Degree
Fordham University

Other Affiliations

Annual Compensation

Salary$200,000
Total Annual Compensation$200,000

Stocks Options

Restricted Stock Awards$2,826,000
All Other Compensation$61,365
Unexercisable Options$100,000
Total Number of Options$100,000

Total Compensation

Total Annual Cash Compensation$340,515
Total Short Term Compensation$200,000
Other Long Term Compensation$2,887,365
Total Calculated Compensation$6,483,425
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Barry D. Quart Pharm.D.Chief Executive Officer and Director
Heron Therapeutics, Inc.
$551.6K
Richard F. Pops Chairman and Chief Executive Officer
Alkermes plc
$881.0K
David M. Stack Chairman and Chief Executive Officer
Pacira Pharmaceuticals, Inc.
$1.2M
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$477.4K
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Tesaro, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.